Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
- Krzysztof Strojek
- , Kun Ho Yoon
- , Veronika Hruba
- , Jennifer Sugg
- , Anna Maria Langkilde
- , Shamik Parikh
Research output: Contribution to journal › Article › peer-review
72
Scopus
citations